Elanco Animal Health Incorporated
ELAN
$24.88
-$1.21-4.64%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.72B | 4.59B | 4.48B | 4.43B | 4.44B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.72B | 4.59B | 4.48B | 4.43B | 4.44B |
| Cost of Revenue | 2.12B | 2.07B | 2.03B | 2.00B | 2.00B |
| Gross Profit | 2.59B | 2.52B | 2.45B | 2.43B | 2.44B |
| SG&A Expenses | 1.42B | 1.39B | 1.36B | 1.31B | 1.31B |
| Depreciation & Amortization | 543.00M | 534.00M | 527.00M | 522.00M | 527.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.46B | 4.34B | 4.27B | 4.18B | 4.18B |
| Operating Income | 259.00M | 247.00M | 215.00M | 245.00M | 257.00M |
| Income Before Tax | -224.00M | -16.00M | 593.00M | 536.00M | 488.00M |
| Income Tax Expenses | 8.00M | -52.00M | 159.00M | 163.00M | 150.00M |
| Earnings from Continuing Operations | -232.00 | 36.00 | 434.00 | 373.00 | 338.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -232.00M | 36.00M | 434.00M | 373.00M | 338.00M |
| EBIT | 259.00M | 247.00M | 215.00M | 245.00M | 257.00M |
| EBITDA | 908.00M | 882.00M | 842.00M | 863.00M | 879.00M |
| EPS Basic | -0.47 | 0.07 | 0.88 | 0.75 | 0.68 |
| Normalized Basic EPS | 0.02 | 0.03 | -0.02 | 0.01 | 0.00 |
| EPS Diluted | -0.48 | 0.06 | 0.86 | 0.74 | 0.67 |
| Normalized Diluted EPS | 0.02 | 0.03 | -0.02 | 0.01 | 0.00 |
| Average Basic Shares Outstanding | 1.99B | 1.98B | 1.98B | 1.98B | 1.98B |
| Average Diluted Shares Outstanding | 1.99B | 1.99B | 1.99B | 1.99B | 1.98B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |